If you made any changes in Pure these will be visible here soon.

Research Output 1990 2019

Filter
Letter

Serum and urinary macrophage migration inhibitory factor (MIF) in primary Sjögren's syndrome

Vincent, F. B., Lang, T., Kandane-Rathnayake, R. K., Downie-Doyle, S., Morand, E. F. & Rischmueller, M., 1 May 2019, In : Joint Bone Spine. 86, 3, p. 393-395 3 p.

Research output: Contribution to journalLetterOtherpeer-review

Serum soluble Fas and Fas ligand (FasL) in primary Sjögren's syndrome

Vincent, F. B., Bubicich, M., Downie-Doyle, S., Mackay, F., Morand, E. F. & Rischmueller, M., 1 May 2019, In : Clinical and Experimental Rheumatology. 37, 3, p. 254-256 3 p.

Research output: Contribution to journalLetterOtherpeer-review

Serum soluble Fas and Fas ligand (FasL) in primary Sjögren’s syndrome

Vincent, F. B., Bubicich, M., Downie-Doyle, S., Mackay-Fisson, F., Morand, E. F. & Rischmueller, M., 2019, (Accepted/In press) In : Clinical and Experimental Rheumatology. 3 p.

Research output: Contribution to journalLetterResearchpeer-review

2015

Remission in SLE: closing in on the target

van Vollenhoven, R. F., Voskuyl, A. E., Morand, E. F. & Aranow, C. B., 2015, In : Annals of the Rheumatic Diseases. 74, 12, p. 2103 - 2106 4 p.

Research output: Contribution to journalLetterOther

2014

Macrophage migration inhibitory factor: a potential biomarker for cardiovascular disease in persons with HIV?

Woolley, I. J., Ayoub, S., Crowe, S. M., Westhorpe, C. L., Cherry, C., Visvanathan, K. & Morand, E. F., 2014, In : AIDS. 28, 11, p. 1693 - 1694 2 p.

Research output: Contribution to journalLetterResearchpeer-review

Open Access
2004

Lower level of synovial fluid interferon-γ in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomais reactive arthritis (multiple letters) [7]

Cuchacovich, R., Espinoza, L. R., Bas, S., Gabay, C., Hoi, A. Y. & Morand, E. F., 1 Feb 2004, In : Rheumatology. 43, 2, p. 249-251 3 p.

Research output: Contribution to journalLetterOtherpeer-review

2003

Churg-Strauss syndrome: the use of cyclophosphamide in severe complications

Hoi, A. & Morand, E. F., 2003, In : Rheumatology. 42, p. 390 - 391 2 p.

Research output: Contribution to journalLetterOther

Churg-Strauss syndrome: The use of cyclophosphamide in mononeuritis [7]

Hoi, A. Y. & Morand, E. F., 1 Feb 2003, In : Rheumatology. 42, 2, p. 390-391 2 p.

Research output: Contribution to journalLetterOtherpeer-review

1995

Reply

Morand, E. F. & Hall, J., 1 Jan 1995, In : Arthritis & Rheumatism. 38, 5, p. 725-726 2 p.

Research output: Contribution to journalLetterOtherpeer-review

1994

Combination therapy with methotrexate and sulphasalazine in rheumatoid arthritis-tolerance of therapy

Axtens, R. S. K., Morand, E. F. & Lilejohn, G. O., 1 Jan 1994, In : Annals of the Rheumatic Diseases. 53, 10, 1 p.

Research output: Contribution to journalLetterOtherpeer-review